REGN
Regeneron Pharmaceuticals Inc (REGN) Q1 2025 Earnings Call
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q1 2025 Earnings Conference
Regeneron Pharmaceuticals Inc (REGN) Regeneron Science Talent Search 2026 Recognizes America’s Top Young Scientists, Awarding More Than $1.8 Million to High School Seniors for Innovative Research in Computational Mathematics, Neural Science, and Blood Cancer Treatment
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Other Release
Regeneron Pharmaceuticals Inc (REGN) Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Other Release
Regeneron Pharmaceuticals Inc (REGN) Barclays 28th Annual Global Healthcare Conference
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Corporate Conference
Regeneron Pharmaceuticals Inc (REGN) Dupixent (dupilumab) Recommended for EU Approval to Treat Chronic Spontaneous Urticaria (CSU) in Young Children with Ongoing Symptoms Despite Treatment
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Other Release
Regeneron Pharmaceuticals Inc (REGN) Regeneron Renews Sponsorship of the Regeneron Science Talent Search Through 2036, Committing an Additional $150 Million to Empower the Next Generation of Science and Technology Leaders
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Other Release
Regeneron Pharmaceuticals Inc (REGN) Dupixent® (dupilumab) Approved in the U.S. as the First and Only Medicine for Allergic Fungal Rhinosinusitis (AFRS)
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Other Release
Regeneron Pharmaceuticals Inc (REGN) Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Other Release
Regeneron Pharmaceuticals Inc (REGN) Q4 2025 Earnings Call
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) Q4 2025 Earnings Conference
Regeneron Pharmaceuticals Inc (REGN) Leerink Partners 2026 Global Healthcare Conference
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Corporate Conference